Craft

Pear Therapeutics

Stock Price

$0

2023-06-20

Market Capitalization

$4.2 M

2023-06-20

Revenue

$12.7 M

FY, 2022

Pear Therapeutics Summary

Company Summary

Overview
Pear Therapeutics is a company developing drug-software combination therapies to help people with mental and behavioral health issues. The company combines pharmaceutical therapy with software technology, such as digital applications and games. Pear has products at different stages of the development pipeline, including marketed products, across therapeutic areas such as mental health disorders, severe insomnia, and multiple sclerosis.
Type
Public
Status
Closed
Founded
2013
HQ
Boston, MA, US | view all locations
Website
https://peartherapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Corey McCann

    Corey McCann, President & CEO, Director

  • Chris Guiffre
  • Yuri Maricich

    Yuri Maricich, Chief Medical Officer, Head of Development

  • Erin Brenner

    Erin Brenner, Chief Product Development Officer

Operating MetricsView all

Commercial Partners

2

Aug, 2019

FDA Authorization Stage Products (Partnered)

2

Aug, 2019

POC Stage Products (Internal)

4

Aug, 2019

LocationsView all

2 locations detected

  • Boston, MA HQ

    United States

    200 State St

  • San Francisco, CA

    United States

    201 Mission Street

Pear Therapeutics Financials

Summary Financials

Revenue (FY, 2022)
$12.7M
Gross profit (FY, 2022)
$4.5M
Net income (FY, 2022)
($75.5M)
Cash (FY, 2022)
$48.3M
EBIT (FY, 2022)
($123.4M)
Enterprise value
($6.5M)

Footer menu